A massive and much-anticipated phase 3 trial of an experimental tuberculosis (TB) vaccine is set to proceed after funding for it has been secured from two large philanthropies. If the trial’s findings are positive, the vaccine is likely to become the first new TB vaccine in over a hundred years to be widely used. Marcus Low reports.
In March this year, the director-general of the Northern Cape government, Justice Bekebeke during a parliamentary oversight visit acknowledged that about 80% of the health facilities in the province did not meet their performance targets of finding people with tuberculosis and helping them complete treatment. Refilwe Mochoari looked at the statistics and spoke to several roleplayers about why the province is missing its TB targets.
In 1984, the then-head of Brooklyn Chest TB Hospital, Dr David Jenkin lamented inadequate services for TB patients, writing that “it is unflattering to realize that only war and pestilence appear able to bring more beds for TB sufferers”. Almost 40 years later, despite major scientific advances, TB hospitals like Brooklyn Chest remain important for treating complicated forms of the disease, where specialised healthcare staff can monitor medication interactions and side-effects. Biénne Huisman takes a look back at the hospital’s 151-year history and the difference it is making in the lives of children with TB today.
Every year, tens of thousands of people who fall ill with tuberculosis in South Africa are not diagnosed. Because of this, there has been much focus on testing people earlier rather than waiting for them to show up at clinics when they are already sick. One potential solution, explored in a trial called XACT 2, is community-based testing using a point-of-care molecular test. Tiyese Jeranji spoke to experts involved with XACT 2 and unpacks the study’s findings that were recently published in Nature Medicine.
People in South Africa who fall ill with tuberculosis (TB) often also have other health issues. HIV, which drives much of the TB epidemic in South Africa, is the most obvious co-infection, but people who fall ill with TB are also more likely to have diabetes and mental health problems than the general public. Tiyese Jeranji spoke to local experts about the interesting links between TB and liver problems.
South Africa’s new National Strategic Plan for HIV, TB, and STIs 2023-2028 and the country’s TB Recovery Plan necessitate a sharp increase in TB testing and increased enrolment into care, which will require additional spending on testing and medicines. Sihle Mahonga Ndawonde argues that a joint committee should be set up to review and interrogate provincial departments’ resource allocation decisions for the next three years.
Almost two years ago, a study found that a breakthrough four-month treatment regimen for tuberculosis is as effective as the current six-month regimen. The time is now to join together for the thoughtful implementation of this new regimen, argue Yuri F. van der Heijden, Violet Chihota, and Salome Charalambous.
South Africa’s National Strategic Plan for HIV, TB and STIs (2023 – 2028) was launched on Friday at Tlhabane Stadium in Rustenburg, North West as the world commemorated World TB Day. Nthusang Lefafa attended the event and spoke to experts and activists about the state of TB and HIV and the work that lies ahead with the new NSP.
Despite advances in paediatric TB care, substantial challenges remain. If we are to heed the call for this year’s World TB Day – ‘Yes! We can end TB’ – we will need to significantly ramp up dedicated investment for an integrated approach to addressing TB in children, argues Dr Sipho Nyathi.
On 9 March, Professor Muki Shey received a silver award from the South African Medical Research Council for his “outstanding contribution to health research”. Shey is spearheading research into TB in healthcare workers from around Cape Town, scanning for those who over at least five years of high exposure to the disease at hospitals or clinics have never been infected. Biénne Huisman spoke to him about his journey from the North West of Cameroon to a lab at UCT and the value of ploughing back to help develop the next generation.
The South African TB Recovery Plan was developed to try and reverse the negative effects of the COVID-19 pandemic on the country’s TB response. On World TB Day, authors from TB Proof (a leading TB activist group) assess how the recovery is going and identify four key areas where further intervention is needed.
South Africa’s recently published guidelines for the treatment of tuberculosis (TB) infection have been welcomed by several experts. Among others, the guidelines endorse the use of a three-month course of TB preventive therapy as opposed to the old six-month course. But, while the intention is to roll out the three-month course quite widely, supply constraints may delay things. Tiyese Jeranji reports.
